These outlier SNPs were located primarily in genes that were associated with both lipid biomarkers and AMD (e.g., CETP and APOE); therefore, removing these SNPs would affect our estimated effect sizes and study power. The gene discussed is APOE; the disease is age-related macular degeneration.